IPO registrations (S-1, F-1) · Registrants
AMYRIS, INC.
- SEC CIK
- 1365916 · filings on EDGAR ↗
- Former names
- AMYRIS BIOTECHNOLOGIES INC (2006–2010)
- Registration
- Form S-1, first filed 2010-04-16, last 2020-07-10; 4 initial registrations, 9 amendments
- Outcome
- Final prospectus filed 2010-09-28; declared effective 2010-09-27
- Industry (SIC)
- Industrial Organic Chemicals 2860
- Incorporated in
- DE
- Business address
- 5885 HOLLIS STREET, SUITE 100, Emeryville, CA 94608
- EIN
- 55-0856151
- EDGAR entity type
- operating
- Insiders and CEO pay
- AMYRIS, INC. on the corporate pages
Offering terms
- Final price
- $16.00 per share (424B4 filed 2010-09-28, an initial public offering)
- Shares sold
- 5,300,000
- Gross proceeds
- $84,800,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol AMRS
- Lead underwriters
- Morgan Stanley; Goldman Sachs; J.P. Morgan
- Syndicate
- Banco Itaú; Stifel
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: AMYRIS, INC. EXACT (EIN (EXACT, as the state registration reports it))
- Form 5500 plan sponsor: AMYRIS, INC. EXACT (EIN (EXACT))
- Federal award recipient: AMYRIS, INC. Fuzzy (name and state)
- Form D issuer: AMYRIS, INC. EXACT (CIK (EXACT))
- Lobbying client: AMYRIS INC Fuzzy (name and state)
- SEC filer: AMYRIS, INC. EXACT (CIK (EXACT))
Filings 29
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2010-04-16 | S-1 | S-1 (registration) | AMYRIS BIOTECHNOLOGIES INC | 0001193125-10-085595 ↗ |
| 2010-05-25 | S-1/A | S-1/A (amendment) | AMYRIS BIOTECHNOLOGIES INC | 0001193125-10-128313 ↗ |
| 2010-06-23 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-144333 ↗ |
| 2010-06-28 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-148810 ↗ |
| 2010-07-06 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-154155 ↗ |
| 2010-08-17 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-190513 ↗ |
| 2010-08-31 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-201443 ↗ |
| 2010-09-13 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-208312 ↗ |
| 2010-09-20 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-212804 ↗ |
| 2010-09-24 | S-1/A | S-1/A (amendment) | AMYRIS, INC. | 0001193125-10-216023 ↗ |
| 2010-09-27 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-10-002780 ↗ |
| 2010-09-28 | 424B4 | 424B4 (final prospectus) | AMYRIS, INC. | 0001193125-10-218728 ↗ |
| 2012-05-04 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-12-001422 ↗ |
| 2015-04-15 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-15-000896 ↗ |
| 2015-05-20 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-15-001416 ↗ |
| 2015-06-05 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-15-001549 ↗ |
| 2015-11-10 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-15-003011 ↗ |
| 2015-11-27 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-15-003152 ↗ |
| 2017-01-06 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-17-000049 ↗ |
| 2017-02-06 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-17-000297 ↗ |
| 2017-10-17 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-17-002699 ↗ |
| 2017-12-01 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-17-003106 ↗ |
| 2018-10-11 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-18-002602 ↗ |
| 2019-11-13 | S-1 | S-1 (registration) | AMYRIS, INC. | 0001193125-19-290256 ↗ |
| 2019-12-17 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-19-002840 ↗ |
| 2020-05-12 | S-1 | S-1 (registration) | AMYRIS, INC. | 0001365916-20-000079 ↗ |
| 2020-05-29 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-20-001284 ↗ |
| 2020-07-10 | S-1 | S-1 (registration) | AMYRIS, INC. | 0001365916-20-000119 ↗ |
| 2020-07-23 | EFFECT | EFFECT (declared effective) | AMYRIS, INC. | 9999999995-20-001905 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2010-09-24 | S-1/A | registration statement | $4.31 | 425,254 | $1,832,844 | 0 | primary document; price sentence, shares headline, proceeds computed | document ↗ | ||
| 2010-09-28 | 424B4 | final prospectus | $16.00 | 5,300,000 | $84,800,000 | Nasdaq AMRS | 5 | primary document; price sentence, shares headline, proceeds table, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Alexander Ralph | Director | 5 | 2010–2012 | ||
| Boynton Peter | Officer | Chief Commercial Officer | 7 | 2010–2012 | |
| Cherry Joel | Officer | President of R&D; SVP, Res. Progs. & Ops. | 37 | 2010–2019 | |
| DOERR L JOHN | Director; Director,TenPercentOwner | 60 | 2010–2024 | ||
| DUYK GEOFFREY M | Director | 19 | 2010–2024 | ||
| HILLEMAN JERYL L | Officer | Chief Financial Officer | 6 | 2010–2011 | |
| Kaul Samir | Director; Director,TenPercentOwner | 12 | 2010–2011 | ||
| Khosla Ventures Associates III, LLC | TenPercentOwner | 2 | 2010 | ||
| Khosla Ventures Associates II, LLC | TenPercentOwner | 2 | 2010 | ||
| Khosla Ventures III, L.P. | TenPercentOwner | 2 | 2010 | ||
| Khosla Ventures II, L.P. | TenPercentOwner | 2 | 2010 | ||
| KLEINER PERKINS CAUFIELD & BYERS XII, LLC | TenPercentOwner | 2 | 2010 | ||
| KPCB XII Associates, LLC | TenPercentOwner | 2 | 2010 | ||
| KPCB XII Founders Fund, LLC | TenPercentOwner | 2 | 2010 | ||
| LEVINSON ARTHUR D | Director | 6 | 2010–2013 | ||
| Lievense Jefferson | Officer | EVP of Process Development; SVP, Process Dev. & Mfg. | 7 | 2010–2012 | |
| Melo John | Director,Officer | President and CEO | 59 | 2010–2022 | |
| PICHETTE PATRICK | Director | 4 | 2010–2012 | ||
| Piwnica Carole | Director | 13 | 2010–2020 | ||
| Portela Mario | Officer | Chief Operating Officer; President of Global Operations | 5 | 2010–2012 | |
| Reiling Keith Kinkead | Director; Director,Officer | SVP, Corp. Dev. | 3 | 2010–2011 | |
| Reinach Fernando de Castro | Director | 11 | 2010–2017 | ||
| Renninger Neil | Director; Director,Officer; Officer | Chief Technical Officer | 15 | 2010–2012 | |
| Tompkins Tamara | Officer | EVP, Gen'l Counsel & Secretary; SVP, Gen'l Counsel & Sec'ty; SVP, Gen??l Counsel & Sec??ty | 9 | 2010–2012 | |
| TOTAL ENERGIES NOUVELLES ACTIVITES USA | Director,TenPercentOwnerOther; TenPercentOwner | 19 | 2010–2017 | ||
| VK Services, LLC | TenPercentOwner | 2 | 2010 | ||
| Boisseau Philippe | Director; Director,TenPercentOwner | 16 | 2010–2016 | ||
| Richardson James Young | Officer | SVP, Vertical Mkts & Sales Ops; SVP, Vert Markets and Sales Op | 2 | 2011 | |
| Diniz Paulo Sergio de Oliveira | Officer | CEO, Amyris Brasil Ltda.; CEO, Amyris Brasil S.A.; Interim Chief Financial Officr | 7 | 2011–2014 | |
| Al Thani Sheikh Abdullah bin Khalifa | Director | 12 | 2012–2018 | ||
| MILLS STEVEN RICHARD | Director; Officer | Chief Financial Officer | 16 | 2012–2024 | |
| Patel Mark | Officer | SVP, Commercial Operations | 1 | 2012 | |
| CHUA NAM HAI DR | Director | 5 | 2012–2014 | ||
| LOEB GARY | Officer | SVP, Gen'l Counsel & Secretary | 4 | 2012–2013 | |
| Cairnhill Investments (Mauritius) Pte Ltd | TenPercentOwner | 47 | 2012–2018 | ||
| Fullerton Management Pte Ltd | TenPercentOwner | 46 | 2012–2018 | ||
| Maxwell (Mauritius) Pte Ltd | TenPercentOwner | 47 | 2012–2018 | ||
| Temasek Holdings (Private) Ltd | TenPercentOwner | 47 | 2012–2018 | ||
| MCFERSON SUSANNA | Officer | Chief Business Officer; CHIEF BUSINESS OFFICER | 4 | 2013–2014 | |
| Williams R Neil | Director | 9 | 2013–2019 | ||
| WEAVER KAREN | Director,Officer; Officer | Principal Accounting Officer | 21 | 2013–2017 | |
| Khadder Nicholas | Officer | General Counsel and Secretary; General Counsel & Secretary | 13 | 2014–2016 | |
| Yang Patrick Y | Director | 13 | 2014–2020 | ||
| ASADORIAN RAFFI | Officer | Chief Financial Officer | 5 | 2015–2017 | |
| KLAEIJSEN ABRAHAM | Director | 5 | 2015–2017 | ||
| Georgiadis Mary Margaret Hastings | Director | 5 | 2015–2016 | ||
| VUILLEZ CHRISTOPHE | Director | 1 | 2016 | ||
| VALIASEK KATHLEEN | Officer | Chief Business Officer; Chief Financial Officer | 12 | 2017–2020 | |
| Total Raffinage Chimie | Director,TenPercentOwnerOther | 4 | 2017–2018 | ||
| Eykerman Philip | Director | 8 | 2017–2022 | ||
| DSM International B.V. | Director,TenPercentOwner; TenPercentOwner | 4 | 2017–2021 | ||
| Koninklijke DSM N.V. | Director,TenPercentOwner; TenPercentOwner | 4 | 2017–2021 | ||
| KELSEY NICOLE | Officer | CHIEF LEGAL OFFICER- SECRETARY; General Counsel and Secretary; GENERAL COUNSEL AND SECRETARY | 17 | 2017–2022 | |
| ALVAREZ EDUARDO | Officer | Chief Operating Officer; CHIEF OPERATING OFFICER | 13 | 2017–2023 | |
| GOPPELSROEDER CHRISTOPH | Director | 1 | 2017 | ||
| Kung Frank | Director | 25 | 2017–2024 | ||
| Maloney Tina | Officer | Chief Accounting Officer | 2 | 2018 | |
| Hughes Anthony | Officer | Chief Accounting Officer; CHIEF ACCOUNTING OFFICER | 11 | 2018–2022 | |
| Doerr Ann Howland | Director,TenPercentOwner; TenPercentOwner | 6 | 2018–2024 | ||
| Foris Ventures, LLC | TenPercentOwner | 5 | 2018–2023 | ||
| Hager Barbara | Director,TenPercentOwner; TenPercentOwner | 6 | 2018–2024 | ||
| Vallejo Ventures Trust UTA 21296 | Director,TenPercentOwner; TenPercentOwner | 6 | 2018–2024 | ||
| MCCANN JAMES F | Director | 11 | 2019–2024 | ||
| Qi Lisa | Director | 7 | 2019–2024 | ||
| Wolter Jonathan | Officer | Interim CFO | 1 | 2019 | |
| Kieftenbeld Hermanus | Officer | CFO AND INTERIM CEO; Chief Financial Officer; CHIEF FINANCIAL OFFICER | 13 | 2020–2024 | |
| Washington Julie | Director | 6 | 2020–2024 | ||
| Panchadsaram Ryan | Director | 7 | 2021–2024 | ||
| Dutra Ana | Director | 4 | 2022–2024 | ||
| DREYER ELIZABETH E. | Officer | CHIEF ACCOUNTING OFFICER | 2 | 2022 | |
| Gund Philip J. | Officer | Chief Restructuring Officer | 1 | 2023 | |
| Reiss M. Freddie | Director | 1 | 2023 | ||
| White J. Scott | Director | 1 | 2023 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2022-09-28 | AMYRIS, INC. | Manufacturing | $8,000,000 | $8,000,000 | 1 | 1 |
| 2020-06-22 | AMYRIS, INC. | Manufacturing | $199,999,929 | $199,999,929 | 53 | 1 |
| 2020-02-18 | AMYRIS, INC. | Manufacturing | $93,676,610 | $93,676,610 | 7 | 1 |
| 2020-01-29 | AMYRIS, INC. | Manufacturing | $9,750,000 | $9,750,000 | 4 | 1 |
| 2019-12-12 | AMYRIS, INC. | Manufacturing | $3,870,000 | $3,870,000 | 1 | 1 |
| 2019-11-29 | AMYRIS, INC. | Manufacturing | $7,849,997 | $7,849,997 | 2 | 1 |
| 2019-11-12 | AMYRIS, INC. | Manufacturing | $7,740,000 | $7,740,000 | 1 | 1 |
| 2019-10-25 | AMYRIS, INC. | Manufacturing | $5,740,000 | $5,740,000 | 1 | 1 |
| 2019-09-25 | AMYRIS, INC. | Manufacturing | $12,500,000 | $12,500,000 | 3 | 1 |
| 2019-09-12 | AMYRIS, INC. | Manufacturing | $19,000,000 | $19,000,000 | 1 | 1 |
| 2019-08-29 | AMYRIS, INC. | Manufacturing | $9,869,439 | $9,869,439 | 2 | 1 |
| 2019-05-09 | AMYRIS, INC. | Manufacturing | $74,684,532 | $74,684,532 | 9 | 1 |
| 2019-04-30 | AMYRIS, INC. | Manufacturing | $35,569,187 | $35,569,187 | 1 | 1 |
| 2018-12-21 | AMYRIS, INC. | Manufacturing | $60,000,000 | $60,000,000 | 2 | 1 |
| 2018-12-04 | AMYRIS, INC. | Manufacturing | $7,250,000 | $7,250,000 | 1 | 1 |
| 2018-08-31 | AMYRIS, INC. | Manufacturing | $90,970,673 | $90,970,673 | 3 | 1 |
| 2018-04-27 | AMYRIS, INC. | Manufacturing | $38,114,474 | $38,114,474 | 11 | 1 |
| 2017-08-17 | AMYRIS, INC. | Manufacturing | $25,000,000 | $25,000,000 | 1 | 1 |
| 2017-08-17 | AMYRIS, INC. | Manufacturing | $25,000,000 | $25,000,000 | 2 | 1 |
| 2017-06-14 | AMYRIS, INC. | Manufacturing | $5,700,000 | $5,700,000 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | AMYRIS, INC. | CA | State business registries | EIN (EXACT, as the state registration reports it) |
| Form D issuer | AMYRIS, INC. | CA | Form D private offerings | CIK (EXACT) |
| SEC filer | AMYRIS, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Form 5500 plan sponsor | AMYRIS, INC. | EIN (EXACT) | ||
| Federal award recipient | AMYRIS, INC. | Federal spending (USAspending) | name and state | |
| Lobbying client | AMYRIS INC | Federal lobbying (LDA) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.